Open AccessTherapeutic drug monitoring in peritoneal dialysis: A case of nontuberculous mycobacterium catheter‐related infection treated with amikacin
Author(s) -
Kojya Sanae,
Shiohira Hideo,
Sunagawa Yoshitsugu,
Tsuneyoshi Shoji,
Kohagura Kentaro,
Ohya Yusuke,
Yonaha Fusako,
Hokama Nobuo,
Nakamura Katsunori
Publication year - 2020
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.2774
Subject(s) - medicine , amikacin , therapeutic drug monitoring , continuous ambulatory peritoneal dialysis , peritoneal dialysis , dosing , pharmacokinetics , catheter , dialysis , drug , intensive care medicine , antibiotics , surgery , pharmacology , microbiology and biotechnology , biology
Abstract The pharmacokinetics of amikacin makes it difficult to predict the appropriate dosing to avoid harmful side effects in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). The implementation of therapeutic drug monitoring may be useful in controlling amikacin serum concentrations in patients receiving CAPD.